Mallinckrodt, Fresenius Reach $14M Deal On Supply Claims
Drugmaker Mallinckrodt PLC is asking a Delaware bankruptcy judge to approve a $13.9 million settlement with a subsidiary of German pharmaceutical company Fresenius Kabi to end a dispute over supply payments...To view the full article, register now.
Already a subscriber? Click here to view full article